U-BIOPRED (“Unbiased Biomarkers for the Prediction of Respiratory Disease Outcomes”) was a 5-year European-wide IMI-funded project (IMI-115010) which aimed to understand more about severe asthma, determine how it differs from person to person, and uncover new information and ideas that could lead to the creation of effective new treatments.
The IMI-funded U-BIOPRED project released the first classification of severe asthma
U-BIOPRED (“Unbiased Biomarkers for the Prediction of Respiratory Disease Outcomes”) was a 5-year European-wide IMI-funded project (IMI-115010) which aimed to understand more about severe asthma, determine how it differs from person to person, and uncover new information and ideas that could lead to the creation of effective new treatments.
